Pathwork Diagnostics Closes on $30M Series C Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Pathwork Diagnostics today announced it has closed its $30 million Series C financing.

The round was led by Alta Partners and included existing investors Abingworth, Advent Venture Partners, Novus Ventures, Prospect Venture Partners, and Venrock. David Mack, a director at Alta Partners, has joined the board of Pathwork, the Redwood City, Calif., company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.